Alexandra K. W.
- Country
- Austria
- Department
- Department of Medicine III, Division of Endocrinology and Metabolism
Research Overview
- Effect of Muvalaplin on Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: A Phase 3 Randomized Trial
- Randomized Study of Cagrilintide + Semaglutide Combination vs Semaglutide Monotherapy for Weight Loss in Adults with Obesity (± Type 2 Diabetes)
- Efficacy and Safety of Balcinrenone and Dapagliflozin Versus Dapagliflozin in Adults with Chronic Kidney Disease and Albuminuria: A Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 398 of 1021 partner sites.
Specializations
Metabolic Disorders
The investigator demonstrates significant expertise in treating complex metabolic conditions, particularly focusing on Type 2 Diabetes and its intersection with obesity. Their research encompasses innovative therapeutic approaches including novel medications like orforglipron and tirzepatide.
- Diabetes Management
- Obesity Treatment
- Metabolic Syndrome
Their work extends to understanding hormonal interactions in metabolic health, including testosterone supplementation effects in diabetic patients.
Cardiovascular Health
The investigator specializes in cardiovascular risk management in metabolic disorders, with particular attention to preventive cardiology and heart disease prevention in diabetic patients. Their expertise includes evaluation of cardiac biomarkers and cardiovascular outcomes.
- Cardiovascular Risk Assessment
- Cardiac Biomarkers
- Preventive Cardiology
A key focus is the investigation of cardiovascular safety in new therapeutic approaches for obesity and diabetes.
Endocrine Disorders
The investigator has extensive experience in treating complex endocrine conditions, including Cushing Syndrome and hypogonadism. Their research encompasses hormone regulation and its effects on metabolic health.
- Hormonal Disorders
- Endocrine System Regulation
- Steroid Hormone Studies
Their work includes investigation of cholesterol-lowering medications' effects on steroid hormones and related metabolic processes.
Renal Medicine
The investigator has significant expertise in chronic kidney disease management, particularly focusing on innovative therapeutic combinations. Their research includes investigation of treatments for albuminuria and kidney function preservation.
- Kidney Disease Management
- Albuminuria Treatment
- Renal Protection Strategies
Their work emphasizes the connection between kidney disease and metabolic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.